Dimethylmalonic acid
CAS No. 595-46-0
Dimethylmalonic acid( —— )
Catalog No. M33597 CAS No. 595-46-0
Dimethylmalonic acid(2,2-Dimethylmalonic acid) is a short-chain dicarboxylic acid found in human serum that can be used to prevent or retard denaturation of fish actinomyosin in freezing buffer solution (pH 7).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDimethylmalonic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionDimethylmalonic acid(2,2-Dimethylmalonic acid) is a short-chain dicarboxylic acid found in human serum that can be used to prevent or retard denaturation of fish actinomyosin in freezing buffer solution (pH 7).
-
DescriptionDimethylmalonic acid is a short-chain dicarboxylic acid in human serum. Dimethylmalonic acid is also a volatile organic compound detected in alveolar breath.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number595-46-0
-
Formula Weight132.11
-
Molecular FormulaC5H8O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (756.94 mM; Ultrasonic )
-
SMILESCC(C)(C(O)=O)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Zinc Protoporphyrin
Zinc Protoporphyrin is an orally active and competitive inhibitor of heme oxygenase-1 (HO-1) and markedly attenuates the protective effects of Phloroglucinol (PG) against H2O2, and has anti-cancer activity.
-
Oleoylcarnitine
Oleoylcarnitine (Oleoyl-L-carnitine) inhibits adenine nucleotide translocase (AdNT) activity with an ic50 of 14 μM.Oleoylcarnitine is an important indicator of neurodegeneration.
-
Glucagon-Like Peptid...
Glucagon-like peptide 2 (GLP-2) is a recently identified intestinal epithelium-specific growth factor that has been shown to reduce the severity of inflammatory disorders of the intestine in rodent models. Currently Glucagon-Like Peptide 2 is used as a potential therapeutic agent for the human subjects with a broad variety of intestinal diseases characterized by intestinal damage and insufficiency.
Cart
sales@molnova.com